The Indian Council of Medical Research has suggested that it might drop plasma therapy from the national guidelines for treatment of the novel coronavirus, as the treatment was found to be ineffective in halting the infection's progression and reducing mortality.

ICMR Director-General Balram Bhargava noted that India had carried out one of the biggest trials of plasma therapy in the world. "In the light of the trials, we have had discussions in the National Task Force (NTF). Further, we are taking it up with the Joint Monitoring Group (JMG) — it may be deleted from the national guidelines,” he said.

Here's all you need to know.